Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis
- 1 July 2010
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 90 (7) , 1024-1032
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosisBritish Journal of Pharmacology, 2009
- Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses†‡Hepatology, 2009
- Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseHepatology, 2007
- LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liverJournal of Hepatology, 2007
- Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteinsHepatology, 2007
- Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosisGut, 2006
- Thromboxane A2from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: A randomized trialHepatology, 2004
- Induction of cellular resistance against Kupffer cell-derived oxidant stress: A novel concept of hepatoprotection by ischemic preconditioningHepatology, 2003
- The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enoughHepatology, 2002